Skip to search formSkip to main contentSkip to account menu

ZIO 201

Known as: ZIO-201, ZIO201 
National Institutes of Health

Related topics

Related topics

1 relation
isophosphamide mustard

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Samenwerking gemeenten en huisartsenpraktijken is maatwerk
Zorggroep ZIO (Zorg in Ontwikkeling) is sinds 2011 als eerstelijnszorgorganisatie in de regio Maastricht-Heuvelland betrokken bij… 
Review
2015
Review
2015
Simulation of Life Distributions
This chapter introduces the principles underlying the simulation of the probability distributions which typically characterize… 
2011
2011
La Administración Vasca ante la nueva ley de empleo público para Euskadi
espanolLa Comunidad Autonoma de Euskadi se enfrenta al reto de elaborar una Ley de Empleo Publico que de respuesta a las… 
Review
2008
Review
2008
Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.
BACKGROUND Cancer control by radiotherapy (RT) can be improved with concurrent chemotherapy. Outpatient strategies for sarcomas… 
2007
2007
ZIO-201 (isophosphoramide mustard; IPM) is an orally active anti-cancer agent
2007
2007
7524 POSTER ZIO-201, isophosphoramide mustard in advanced sarcoma
2006
2006
1. 「ZIO M900 QUADRA」を使用した3D画像作成のポイントと裏技
2006
2006
Isophosphoramide mustard-lysine (ZIO-201): A potential new alkylator for bone marrow transplants
2006
2006
Isophosphoramide mustard-lysine (IPM-L; ZIO-201): A new alkylator for bone marrow transplants
2005
2005
Isophosphoramide Mustard-Lysine (ZIO-201): Active Moiety of Ifosfamide (IFOS) without Kidney Toxicity.
Ifosfamide (IFOS) and cyclophosphamide (CPA) are widely used anti-cancer drugs. Both are pro-drugs which must be metabolized… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)